Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Soo-Kyung | - |
dc.contributor.author | Choi, Chang Hwan | - |
dc.contributor.author | Chun, Jaeyoung | - |
dc.contributor.author | Lee, Heeyoung | - |
dc.contributor.author | Kim, Eun Sun | - |
dc.contributor.author | Park, Jae Jun | - |
dc.contributor.author | Park, Chan Hyuk | - |
dc.contributor.author | Lee, Bo-In | - |
dc.contributor.author | Jung, Yunho | - |
dc.contributor.author | Park, Dong-Il | - |
dc.contributor.author | Kim, Do Young | - |
dc.contributor.author | Park, Hana | - |
dc.contributor.author | Jeen, Yoon Tae | - |
dc.date.accessioned | 2021-08-11T08:39:03Z | - |
dc.date.available | 2021-08-11T08:39:03Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 1598-9100 | - |
dc.identifier.issn | 2288-1956 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/3244 | - |
dc.description.abstract | The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD. | - |
dc.format.extent | 16 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한장연구학회 | - |
dc.title | Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5217/ir.2019.09155 | - |
dc.identifier.scopusid | 2-s2.0-85079740256 | - |
dc.identifier.wosid | 000510827500003 | - |
dc.identifier.bibliographicCitation | Intestinal research, v.18, no.1, pp 18 - 33 | - |
dc.citation.title | Intestinal research | - |
dc.citation.volume | 18 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 18 | - |
dc.citation.endPage | 33 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002555049 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | B-VIRUS REACTIVATION | - |
dc.subject.keywordPlus | STEM-CELL TRANSPLANTATION | - |
dc.subject.keywordPlus | A VACCINE | - |
dc.subject.keywordPlus | HBV REACTIVATION | - |
dc.subject.keywordPlus | CANCER-PATIENTS | - |
dc.subject.keywordPlus | CYTOTOXIC CHEMOTHERAPY | - |
dc.subject.keywordPlus | IMMUNIZATION PRACTICES | - |
dc.subject.keywordPlus | RHEUMATOID-ARTHRITIS | - |
dc.subject.keywordPlus | GLOBAL EPIDEMIOLOGY | - |
dc.subject.keywordPlus | BOOSTER VACCINATION | - |
dc.subject.keywordAuthor | Inflammatory bowel disease | - |
dc.subject.keywordAuthor | Viral hepatitis | - |
dc.subject.keywordAuthor | Vaccination | - |
dc.subject.keywordAuthor | Prevention | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.